Comparing Actemra vs Adalimumab
Actemra | Adalimumab |
|
---|
Actemra (tocilizumab) | Adalimumab |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Giant Cell Arteritis, COVID-19, Cytokine Release Syndrome, Juvenile Idiopathic Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, Systemic... View more |
Prescription only
Adalimumab is a TNF-alfa inhibitor that may be used to treat a wide range of different inflammatory conditions, such as rheumatoid Arthritis, psoriasis, ankylosing spondylitis, Crohn's disease, and... View more |
Related suggestions Rheumatoid Arthritis
Polyarticular Juvenile Idiopathic Arthritis
Popular comparisons
|
|||||||||||||||
More about Actemra (tocilizumab) | More about Adalimumab | ||||||||||||||||
Generic Status | |||||||||||||||||
No lower-cost generic available |
|||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Actemra has an average rating of 6.9 out of 10 from a total of 45 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 21% reported a negative effect. |
Adalimumab has an average rating of 6.3 out of 10 from a total of 705 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 32% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: Actemra side effects in more detail. |
See also: adalimumab side effects in more detail. |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Actemra prices |
View all adalimumab prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other tocilizumab brands include: Tofidence, Tyenne | Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Humira, Hyrimoz, Idacio, Simlandi, Yuflyma, Yusimry View more | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
210 hours |
480 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 335 drugs are known to interact with Actemra:
|
A total of 480 drugs are known to interact with adalimumab:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
January 08, 2010 |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.